Backbone dynamics of the RNase H domain of HIV-1 reverse transcriptase. 2004

Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
Laboratory of Structural Biology, NIEHS, National Institutes of Health, P.O. Box 12233, Research Triangle Park, North Carolina 27709, USA.

Previous NMR relaxation studies of the isolated RNase H domain of HIV-1 reverse transcriptase at low pH have revealed that it is substantially more dynamic and less ordered than the relatively stable and catalytically active E. coli RNase HI. Using more recently developed techniques, we have investigated the dynamic behavior of the RNase H domain of HIV-1 reverse transcriptase at a more physiological pH (6.8), under a variety of solution conditions: no Mg(2+), 80 mM Mg(2+), and 80 mM Mg(2+) plus AMP ligand. In addition, we have repeated the previous measurements on a sample containing 100 mM sodium acetate, pH 5.4. Under all conditions studied, the order parameters from NMR relaxation analysis are uniformly high (>0.8) for most of the domain with the exception of the C-terminal region. Subtle differences can be found among the conditions studied, although the statistical significance of the differences is marginal. Residues 71-114 show a slight increase in order parameter with the addition of 5'-AMP. Conformational exchange, measured with CPMG relaxation dispersion experiments in the presence of Mg and AMP, were detected for some NH sites, predominantly located in the N-terminal region of the protein near strands beta2 and beta3 and helix alpha(A) (residues 28-69). In contrast with earlier studies indicating pathologically extreme dynamic behavior that apparently correlated with inactivity of the isolated domain, the relaxation analysis under the conditions of the present study yielded parameters that are more similar to those of the active E. coli RNase HI. A comparison of the order parameters obtained from a model-free analysis of the relaxation data with the B-factors in the crystal structures of the RNase H domain, both for the isolated domain and for the full HIV-1 reverse transcriptase structure, suggests that the dynamic behavior is similar in all cases.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D016914 Ribonuclease H A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms as well as RETROVIRUSES. Endoribonuclease H,RNase H,Ribonuclease H, Calf Thymus,RNAase H
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D019906 Nuclear Magnetic Resonance, Biomolecular NMR spectroscopy on small- to medium-size biological macromolecules. This is often used for structural investigation of proteins and nucleic acids, and often involves more than one isotope. Biomolecular Nuclear Magnetic Resonance,Heteronuclear Nuclear Magnetic Resonance,NMR Spectroscopy, Protein,NMR, Biomolecular,NMR, Heteronuclear,NMR, Multinuclear,Nuclear Magnetic Resonance, Heteronuclear,Protein NMR Spectroscopy,Biomolecular NMR,Heteronuclear NMR,Multinuclear NMR,NMR Spectroscopies, Protein,Protein NMR Spectroscopies,Spectroscopies, Protein NMR,Spectroscopy, Protein NMR

Related Publications

Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
November 2012, Chemical biology & drug design,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
July 1991, Behring Institute Mitteilungen,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
December 2000, The Journal of biological chemistry,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
February 2016, Nucleic acids research,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
April 2017, Nucleic acids research,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
August 2023, Molecular diversity,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
September 1990, FEBS letters,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
August 2002, The Journal of biological chemistry,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
October 2006, RNA biology,
Geoffrey A Mueller, and Koteppa Pari, and Eugene F DeRose, and Thomas W Kirby, and Robert E London
November 2023, Journal of natural products,
Copied contents to your clipboard!